Compass Pathways advances U.S. rollout plans, hires incentives reported
Compass Pathways said it is advancing a potential U.S. rollout of its COMP360 psilocybin TRD and PTSD programs, with a rolling NDA targeted for H1 2027. It also granted equity to 31 new hires.